仅当我们所知甚少时，我们才确切地知道。 - Suppr

Suppr

超能文献

We know accurately only when we know little.

作者信息

MacLeod Stuart, Mitton Craig

出版信息

Pharmacoeconomics. 2010;28(2):105-7. doi: 10.2165/11531510-000000000-00000.

DOI:10.2165/11531510-000000000-00000

PMID:20085387

Abstract

摘要

相似文献

We know accurately only when we know little.仅当我们所知甚少时，我们才确切地知道。

Pharmacoeconomics. 2010;28(2):105-7. doi: 10.2165/11531510-000000000-00000.

Linking insurance coverage for innovative invasive procedures with participation in clinical research.将创新性侵入性手术的保险覆盖范围与参与临床研究联系起来。

JAMA. 2011 Nov 9;306(18):2024-5. doi: 10.1001/jama.2011.1631.

Real world data.真实世界数据。

Value Health. 2007 Sep-Oct;10(5):322-3. doi: 10.1111/j.1524-4733.2007.00277.x.

Getting research findings into practice. When to act on the evidence.将研究成果应用于实践。何时依据证据采取行动。

BMJ. 1998 Jul 11;317(7151):139-42. doi: 10.1136/bmj.317.7151.139.

Physician stewardship of health care in an era of finite resources.资源有限时代下医生对医疗保健的管理

JAMA. 2011 Jul 27;306(4):430-1. doi: 10.1001/jama.2011.999.

Lung volume reduction surgery: tempest in a teapot.

J Thorac Cardiovasc Surg. 2003 Mar;125(3):457-9. doi: 10.1067/mtc.2003.434.

An outcomes-based approach to decisions about drug coverage policies in British Columbia.不列颠哥伦比亚省基于结果的药物覆盖政策决策方法。

Psychiatr Serv. 2004 Nov;55(11):1230-2. doi: 10.1176/appi.ps.55.11.1230.

Making sense of the evidence using comparative effectiveness to guide clinical decision making, policy and coverage.利用比较效果研究证据来指导临床决策、政策制定及医保覆盖范围。

Acad Radiol. 2011 Sep;18(9):1065-6. doi: 10.1016/j.acra.2011.06.002.

What explains the diffusion of treatments for mental illness?如何解释精神疾病治疗方法的传播？

Am J Psychiatry. 2008 Nov;165(11):1385-92. doi: 10.1176/appi.ajp.2008.08030334.

Implementing evidence-based medicine through medicare coverage decisions.通过医疗保险覆盖范围决策实施循证医学。

Health Aff (Millwood). 2007 Nov-Dec;26(6):1634-42. doi: 10.1377/hlthaff.26.6.1634.

引用本文的文献

Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel.实施基于结果的罕见病治疗管理准入协议：诺西那生钠和Tisagenlecleucel。

Pharmacoeconomics. 2021 Sep;39(9):1021-1044. doi: 10.1007/s40273-021-01050-5. Epub 2021 Jul 7.

Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.政治及其与循证决策覆盖的交织：专家访谈的定性分析。

BMC Health Serv Res. 2013 Mar 9;13:88. doi: 10.1186/1472-6963-13-88.

Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally.英国国家卫生与临床优化研究所的单一技术评估：国际决策的证据与分析来源

Pharmacoeconomics. 2010;28(5):347-9. doi: 10.2165/11535680-000000000-00000.

本文引用的文献

Access with evidence development in the UK: past experience, current initiatives and future potential.在英国，通过循证方法获取医疗资源：过去的经验、当前的举措和未来的潜力。

Pharmacoeconomics. 2010;28(2):163-70. doi: 10.2165/11531410-000000000-00000.

Access with evidence development: the US experience.循证准入：美国经验。

Pharmacoeconomics. 2010;28(2):153-62. doi: 10.2165/11531050-000000000-00000.

Access with evidence development schemes: a framework for description and evaluation.有证据开发计划的获取：一种描述和评价的框架。

Pharmacoeconomics. 2010;28(2):143-52. doi: 10.2165/11530850-000000000-00000.

Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems.为无法资助的项目提供资金：在将新技术和创新技术引入医疗保健系统的决策中管理不确定性的机制。

Pharmacoeconomics. 2010;28(2):113-42. doi: 10.2165/11530820-000000000-00000.

Principles of design of access with evidence development approaches: a consensus statement from the Banff Summit.采用循证发展方法的获取设计原则：班夫峰会共识声明

Pharmacoeconomics. 2010;28(2):109-11. doi: 10.2165/11530860-000000000-00000.

Comparative effectiveness research and evidence-based health policy: experience from four countries.比较效果研究与循证卫生政策：来自四个国家的经验

Milbank Q. 2009 Jun;87(2):339-67. doi: 10.1111/j.1468-0009.2009.00560.x.

Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.证据与价值：罕见病药物公共报销的要求——肿瘤学案例研究

Can J Clin Pharmacol. 2009 Summer;16(2):e273-81; discussion e282-4. Epub 2009 May 13.

The Alberta Hip and Knee Replacement Project: a model for health technology assessment based on comparative effectiveness of clinical pathways.艾伯塔省髋关节和膝关节置换项目：基于临床路径比较效果的卫生技术评估模型。

Int J Technol Assess Health Care. 2009 Apr;25(2):113-23. doi: 10.1017/S0266462309090163.

Commentary: whose views count in evidence synthesis? And when do they count?评论：在证据综合中谁的观点重要？以及何时重要？

Healthc Policy. 2006 Jan;1(2):55-7.

Accountability for reasonableness: an update.合理性问责制：最新情况

BMJ. 2008 Oct 9;337:a1850. doi: 10.1136/bmj.a1850.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验